300 related articles for article (PubMed ID: 8895487)
1. Induction of hprt gene mutations in splenic T-lymphocytes from the rat exposed in vivo to DNA methylating agents is correlated with formation of O6-methylguanine in bone marrow and not in the spleen.
Jansen JG; de Groot AJ; van Teijlingen CM; Tates AD; Vrieling H; van Zeeland AA
Carcinogenesis; 1996 Oct; 17(10):2183-91. PubMed ID: 8895487
[TBL] [Abstract][Full Text] [Related]
2. Marked differences in the role of O6-alkylguanine in hprt mutagenesis in T-lymphocytes of rats exposed in vivo to ethylmethanesulfonate, N-(2-hydroxyethyl)-N-nitrosourea, or N-ethyl-N-nitrosourea.
Jansen JG; Vrieling H; van Teijlingen CM; Mohn GR; Tates AD; van Zeeland AA
Cancer Res; 1995 May; 55(9):1875-82. PubMed ID: 7728755
[TBL] [Abstract][Full Text] [Related]
3. Molecular analysis of hprt gene mutations in skin fibroblasts of rats exposed in vivo to N-methyl-N-nitrosourea or N-ethyl-N-nitrosourea.
Jansen JG; Mohn GR; Vrieling H; van Teijlingen CM; Lohman PH; van Zeeland AA
Cancer Res; 1994 May; 54(9):2478-85. PubMed ID: 8162597
[TBL] [Abstract][Full Text] [Related]
4. O6-methylguanine is a critical determinant of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone tumorigenesis in A/J mouse lung.
Peterson LA; Hecht SS
Cancer Res; 1991 Oct; 51(20):5557-64. PubMed ID: 1913675
[TBL] [Abstract][Full Text] [Related]
5. Formation and persistence of DNA adducts in pouch skin fibroblasts and liver tissue of rats exposed in vivo to the monofunctional alkylating agents N-methyl-N-nitrosourea or N-ethyl-N-nitrosourea.
Jansen JG; de Groot AJ; van Teijlingen CM; Lohman PH; Mohn GR; Vrieling H; van Zeeland AA
Mutat Res; 1994 May; 307(1):95-105. PubMed ID: 7513828
[TBL] [Abstract][Full Text] [Related]
6. DNA adduct formation and T lymphocyte mutation induction in F344 rats implanted with tumorigenic doses of 1,6-dinitropyrene.
Beland FA
Res Rep Health Eff Inst; 1995 Oct; (72):1-27; discussion 29-39. PubMed ID: 11381742
[TBL] [Abstract][Full Text] [Related]
7. 1,3-butadiene: cancer, mutations, and adducts. Part II: Roles of two metabolites of 1,3-butadiene in mediating its in vivo genotoxicity.
Recio L; Saranko CJ; Steen AM
Res Rep Health Eff Inst; 2000 Mar; (92):49-87; discussion 141-9. PubMed ID: 10925839
[TBL] [Abstract][Full Text] [Related]
8. 1,3-butadiene: cancer, mutations, and adducts. Part III: In vivo mutation of the endogenous hprt genes of mice and rats by 1,3-butadiene and its metabolites.
Walker VE; Meng Q
Res Rep Health Eff Inst; 2000 Mar; (92):89-139; discussion 141-9. PubMed ID: 10925840
[TBL] [Abstract][Full Text] [Related]
9. Site specificity of N-methyl-N-nitrosourea-induced transition mutations in the hprt gene.
Zhang LH; Jenssen D
Carcinogenesis; 1991 Oct; 12(10):1903-9. PubMed ID: 1934271
[TBL] [Abstract][Full Text] [Related]
10. In vivo mutagenicity of ethylene oxide at the hprt locus in T-lymphocytes of B6C3F1 lacI transgenic mice following inhalation exposure.
Walker VE; Sisk SC; Upton PB; Wong BA; Recio L
Mutat Res; 1997 Aug; 392(3):211-22. PubMed ID: 9294020
[TBL] [Abstract][Full Text] [Related]
11. Genotoxicity of 1,3-butadiene and its epoxy intermediates.
Walker VE; Walker DM; Meng Q; McDonald JD; Scott BR; Seilkop SK; Claffey DJ; Upton PB; Powley MW; Swenberg JA; Henderson RF;
Res Rep Health Eff Inst; 2009 Aug; (144):3-79. PubMed ID: 20017413
[TBL] [Abstract][Full Text] [Related]
12. Immunocytochemical identification of DNA adducts, O6-methylguanine and 7-methylguanine, in respiratory and other tissues of rat, mouse and Syrian hamster exposed to 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone.
Van Benthem J; Feron VJ; Leeman WR; Wilmer JW; Vermeulen E; den Engelse L; Scherer E
Carcinogenesis; 1994 Sep; 15(9):2023-9. PubMed ID: 7522985
[TBL] [Abstract][Full Text] [Related]
13. A mouse model for the study of in vivo mutational spectra: sequence specificity of ethylene oxide at the hprt locus.
Walker VE; Skopek TR
Mutat Res; 1993 Jul; 288(1):151-62. PubMed ID: 7686258
[TBL] [Abstract][Full Text] [Related]
14. Mice over-expressing human O6 alkylguanine-DNA alkyltransferase selectively reduce O6 methylguanine mediated carcinogenic mutations to threshold levels after N-methyl-N-nitrosourea.
Allay E; Veigl M; Gerson SL
Oncogene; 1999 Jun; 18(25):3783-7. PubMed ID: 10391687
[TBL] [Abstract][Full Text] [Related]
15. Effect of O6-alkylguanine-DNA alkyltransferase on the frequency and spectrum of mutations induced by N-methyl-N'-nitro-N-nitrosoguanidine in the HPRT gene of diploid human fibroblasts.
Lukash LL; Boldt J; Pegg AE; Dolan ME; Maher VM; McCormick JJ
Mutat Res; 1991; 250(1-2):397-409. PubMed ID: 1944354
[TBL] [Abstract][Full Text] [Related]
16. Mutagenicity of 1,3-butadiene at the Hprt locus of T-lymphocytes following inhalation exposures of female mice and rats.
Meng Q; Henderson RF; Chen T; Heflich RH; Walker DM; Bauer MJ; Reilly AA; Walker VE
Mutat Res; 1999 Aug; 429(1):107-25. PubMed ID: 10434027
[TBL] [Abstract][Full Text] [Related]
17. Genotoxic methylating agents modulate extracellular signal regulated kinase activity through MEK-dependent, glutathione-, and DNA methylation-independent mechanisms in lung epithelial cells.
Wichmann AE; Thomson NM; Peterson LA; Wattenberg EV
Chem Res Toxicol; 2003 Jan; 16(1):87-94. PubMed ID: 12693035
[TBL] [Abstract][Full Text] [Related]
18. Interactions between methylating and pyridyloxobutylating agents in A/J mouse lungs: implications for 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis.
Peterson LA; Thomson NM; Crankshaw DL; Donaldson EE; Kenney PJ
Cancer Res; 2001 Aug; 61(15):5757-63. PubMed ID: 11479212
[TBL] [Abstract][Full Text] [Related]
19. Mutational response at the splenic T-lymphocyte hprt locus in mice treated as neonates: contrasting effects of the carcinogens N-ethyl-N-nitrosourea, dimethylnitrosamine, and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.
Dass SB; Heflich RH; Casciano DA
Environ Mol Mutagen; 1998; 31(3):243-7. PubMed ID: 9585262
[TBL] [Abstract][Full Text] [Related]
20. Frequency and spectrum of ethylnitrosourea-induced mutation at the hprt and lacI loci in splenic lymphocytes of exposed lacI transgenic mice.
Walker VE; Gorelick NJ; Andrews JL; Craft TR; deBoer JG; Glickman BW; Skopek TR
Cancer Res; 1996 Oct; 56(20):4654-61. PubMed ID: 8840980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
